Transient Rise in Serum Interleukin-8 Concentration During Acute Myocardial Infarction

Overview

Journal Br Heart J

Specialty Cardiology & Vascular Diseases

Date 1993 Aug 1

PMID 8038022

Citations 10

Authors

Y Abe

M Kawakami

M Kuroki

T Yamamoto

M Fujii

H Kobayashi

T Yaginuma

A Kashii

M Saito

K Matsushima

Affiliations

Soon will be listed here.

Abstract

Objective: To determine whether interleukin-8 (IL-8, a potent activator of neutrophils) is involved in tissue injury during ischaemia and reperfusion in patients with acute myocardial infarction.

Setting: Teaching hospital.

Subjects: Five consecutive patients with acute Q-wave myocardial infarction, two patients with stable angina who underwent elective percutaneous transluminal coronary angioplasty, and 10 normal controls.

Main Outcome Measure: Serum IL-8 concentration measured by enzyme linked immunosorbent assay (ELISA) over time (every four, eight or 12 hours for 36-72 hours).

Results: All five patients with acute myocardial infarction had a transient but significant rise in serum IL-8 concentration (13-1100 ng/l) within 22 hours after the onset of symptoms, whereas IL-8 was not detected in any of the samples from patients with angina pectoris or normal controls. One patient who died of pump failure and two patients who had mild congestive heart failure showed the highest values (1100, 920, and 190 ng/l respectively).

Conclusions: Serum IL-8 concentration showed a transient rise during the very early phase of acute myocardial infarction. In combination with several recent lines of evidence indicating the importance of injurious activities of neutrophils as a cause of tissue damage in acute myocardial infarction and the potent stimulation of neutrophils by IL-8, these results strongly suggest that IL-8 is important in the development of myocardial injury in acute myocardial infarction.

Citing Articles

Pathophysiological Effects of Various Interleukins on Primary Cell Types in Common Heart Disease.

Liu Y, Zhang D, Yin D Int J Mol Sci. 2023; 24(7).

PMID: 37047468 PMC: 10095356. DOI: 10.3390/ijms24076497.

Canonical NF-κB p65, but Not p105, Contributes to IL-1β-Induced IL-8 Expression in Cardiac Fibroblasts.

Mizuno M, Nakano R, Nose S, Matsumura M, Nii Y, Kurogochi K Front Immunol. 2022; 13:863309.

PMID: 35514973 PMC: 9065446. DOI: 10.3389/fimmu.2022.863309.

Evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary study.

Goggs R, Cremer S, Brooks M Vet Rec Open. 2020; 7(1):e000366.

PMID: 32821395 PMC: 7418665. DOI: 10.1136/vetreco-2019-000366.

Role of cytokines and inflammation in heart function during health and disease.

Bartekova M, Radosinska J, Jelemensky M, Dhalla N Heart Fail Rev. 2018; 23(5):733-758.

PMID: 29862462 DOI: 10.1007/s10741-018-9716-x.

Canine pyometra: a model for the analysis of serum CXCL8 in inflammation.

Haas M, Kaup F, Neumann S J Vet Med Sci. 2015; 78(3):375-81.

PMID: 26522810 PMC: 4829503. DOI: 10.1292/jvms.15-0415.

References

Hearse D . Reperfusion of the ischemic myocardium. J Mol Cell Cardiol. 1977; 9(8):605-16. DOI: 10.1016/s0022-2828(77)80357-x. View

Ko Y, Mukaida N, Panyutich A, Voitenok N, Matsushima K, Kawai T . A sensitive enzyme-linked immunosorbent assay for human interleukin-8. J Immunol Methods. 1992; 149(2):227-35. DOI: 10.1016/0022-1759(92)90254-q. View

Romson J, Hook B, Kunkel S, Abrams G, Schork M, Lucchesi B . Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 1983; 67(5):1016-23. DOI: 10.1161/01.cir.67.5.1016. View

Babior B . The respiratory burst of phagocytes. J Clin Invest. 1984; 73(3):599-601. PMC: 425058. DOI: 10.1172/JCI111249. View

Bednar M, Smith B, Pinto A, Mullane K . Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Circ Res. 1985; 57(1):131-41. DOI: 10.1161/01.res.57.1.131. View

Ferrari R, Ceconi C, Curello S, Guarnieri C, Caldarera C, Albertini A . Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol. 1985; 17(10):937-45. DOI: 10.1016/s0022-2828(85)80074-2. View

Engler R, Dahlgren M, Peterson M, Dobbs A, Schmid-Schonbein G . Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. Am J Physiol. 1986; 251(1 Pt 2):H93-100. DOI: 10.1152/ajpheart.1986.251.1.H93. View

Engler R, Dahlgren M, MORRIS D, Peterson M, Schmid-Schonbein G . Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol. 1986; 251(2 Pt 2):H314-23. DOI: 10.1152/ajpheart.1986.251.2.H314. View

Zweier J, Flaherty J, WEISFELDT M . Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A. 1987; 84(5):1404-7. PMC: 304438. DOI: 10.1073/pnas.84.5.1404. View

10.

Mullane K, Salmon J, Kraemer R . Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury. Fed Proc. 1987; 46(7):2422-33. View

11.

Schroder J, Mrowietz U, Morita E, Christophers E . Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol. 1987; 139(10):3474-83. View

12.

Yoshimura T, Matsushima K, Tanaka S, Robinson E, Appella E, Oppenheim J . Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci U S A. 1987; 84(24):9233-7. PMC: 299727. DOI: 10.1073/pnas.84.24.9233. View

13.

Simpson P, Todd 3rd R, Fantone J, Mickelson J, Griffin J, Lucchesi B . Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest. 1988; 81(2):624-9. PMC: 329614. DOI: 10.1172/JCI113364. View

14.

Peveri P, Walz A, DEWALD B, Baggiolini M . A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med. 1988; 167(5):1547-59. PMC: 2188939. DOI: 10.1084/jem.167.5.1547. View

15.

Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W . Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med. 1988; 167(6):1883-93. PMC: 2189694. DOI: 10.1084/jem.167.6.1883. View

16.

Larsen C, Anderson A, Appella E, Oppenheim J, Matsushima K . The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science. 1989; 243(4897):1464-6. DOI: 10.1126/science.2648569. View

17.

Schroder J . The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate. J Exp Med. 1989; 170(3):847-63. PMC: 2189417. DOI: 10.1084/jem.170.3.847. View

18.

Paccaud J, Schifferli J, Baggiolini M . NAP-1/IL-8 induces up-regulation of CR1 receptors in human neutrophil leukocytes. Biochem Biophys Res Commun. 1990; 166(1):187-92. DOI: 10.1016/0006-291x(90)91929-m. View

19.

Leonard E, Skeel A, Yoshimura T, Noer K, Kutvirt S, Van Epps D . Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. J Immunol. 1990; 144(4):1323-30. View

20.

Bell D, Jackson M, Nicoll J, Millar A, Dawes J, Muir A . Inflammatory response, neutrophil activation, and free radical production after acute myocardial infarction: effect of thrombolytic treatment. Br Heart J. 1990; 63(2):82-7. PMC: 1024331. DOI: 10.1136/hrt.63.2.82. View